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Abstract
Background: Verbal autopsy methods are critically important for evaluating the leading causes of death in
populations without adequate vital registration systems. With a myriad of analytical and data collection approaches,
it is essential to create a high quality validation dataset from different populations to evaluate comparative method
performance and make recommendations for future verbal autopsy implementation. This study was undertaken to
compile a set of strictly defined gold standard deaths for which verbal autopsies were collected to validate the
accuracy of different methods of verbal autopsy cause of death assignment.
Methods: Data collection was implemented in six sites in four countries: Andhra Pradesh, India; Bohol, Philippines;
Dar es Salaam, Tanzania; Mexico City, Mexico; Pemba Island, Tanzania; and Uttar Pradesh, India. The Population
Health Metrics Research Consortium (PHMRC) developed stringent diagnostic criteria including laboratory,
pathology, and medical imaging findings to identify gold standard deaths in health facilities as well as an
enhanced verbal autopsy instrument based on World Health Organization (WHO) standards. A cause list was
constructed based on the WHO Global Burden of Disease estimates of the leading causes of death, potential to
identify unique signs and symptoms, and the likely existence of sufficient medical technology to ascertain gold
standard cases. Blinded verbal autopsies were collected on all gold standard deaths.
Results: Over 12,000 verbal autopsies on deaths with gold standard diagnoses were collected (7,836 adults, 2,075
children, 1,629 neonates, and 1,002 stillbirths). Difficulties in finding sufficient cases to meet gold standard criteria
as well as problems with misclassification for certain causes meant that the target list of causes for analysis was
reduced to 34 for adults, 21 for children, and 10 for neonates, excluding stillbirths. To ensure strict independence
for the validation of methods and assessment of comparative performance, 500 test-train datasets were created
from the universe of cases, covering a range of cause-specific compositions.
Conclusions: This unique, robust validation dataset will allow scholars to evaluate the performance of different
verbal autopsy analytic methods as well as instrument design. This dataset can be used to inform the
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implementation of verbal autopsies to more reliably ascertain cause of death in national health information
systems.
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Background
Verbal autopsy (VA) is a critically important tool to
measure causes of death in populations without com-
plete medical certification of causes of death. A variety
of methods have been proposed for VA cause assign-
ment [1,2], ranging from physician-certified verbal
autopsy (PCVA) [3,4] to data-derived algorithms [5-7],
various applications of Bayes’ theorem [8-13], and direct
statistical estimation of cause fractions [14]. New meth-
ods to analyze VAs and attribute causes of death to
them are now being developed [15-19], and it is likely
that there will continue to be new methods and refine-
ments. Given both the increasing demand for good
cause of death information for the world’s poorest
populations and the expanding array of VA approaches,
it is essential to be able to assess the performance of
these options in a scientific and comparable manner.
Several validation studies of VA cause assignment
methods have been published [2,3,12,20-31]. Results of
validation studies to date, however, have been chal-
lenged on several grounds [32-34]. First, previously pub-
lished validation studies compare the cause of death for
individuals derived from verbal autopsy to the cause of
death recorded in hospital records or that derived from
independent review of hospital medical records. The
quality of record keeping and the laboratory, medical
imaging, and pathological services available in many
developing country hospitals can be extremely poor.
This is especially true in resource-poor remote areas
where validation studies have been undertaken. As a
result, many of these validation studies are actually com-
parisons of two imperfect cause of death assignment
approaches: low-quality hospital-assigned cause of death
and the verbal autopsy. In the language of psycho-
metrics, most studies provide information on convergent
validity rather than a comparison to a true gold stan-
dard known as criterion validity [35]. Second, many stu-
dies start with a community sample and then trace back
as many deaths to hospital records as possible. The
resulting studies often yield small numbers for many
causes, so that published results only cover the conver-
gent validity of VA with hospital-assigned (or derived)
causes of death for a limited number of causes of death.
For many important causes of death such as liver cir-
rhosis, chronic obstructive pulmonary disease (COPD),
or specific sites of cancer, there is essentially no pub-
lished information on performance of VA. Third, valida-
tion studies often do not provide details on the exact
items in the VA instrument, the training of interviewers,
the training of physicians for PCVA, the coding of death
certificates completed by physicians for PCVA, or the
protocol used to extract a cause of death from the hos-
pital records.
The Population Health Metrics Research Consortium
(PHMRC) gold standard verbal autopsy validation study
was initiated in 2005 to address these research limita-
tions and to ensure that comparative assessments of VA
performance were based on clinically reliable diagnoses.
We designed the study as a multisite collaboration that
aims to address some of the key limitations of previous
validation studies and stimulate the development of new
methods or refinements of existing methods. The pri-
mary goal was to collect a dataset that would help pro-
vide more definitive answers as to which VA approaches
are more valid and to capture data in a standardized
way. In this paper, we describe the design of the study,
the criteria used to establish a gold standard (GS) cause
of death, the implementation of fieldwork, and the crea-
tion of standardized datasets for developing and testing
new methods.
Methods
Data collection sites
Gold standard VA data collection was implemented in
six sites in four countries: Andhra Pradesh, India; Bohol,
Philippines; Dar es Salaam, Tanzania; Mexico City, Mex-
ico; Pemba Island, Tanzania; and Uttar Pradesh, India.
Table 1 shows the age and sex distribution for the dece-
dents represented in this study, as well as the national
life expectancy.
Research at the Andhra Pradesh, India, site was imple-
mented and coordinated through the George Institute
for Global Health, India, and was centered in the main
capital city, Hyderabad, as well as the neighboring areas
of Ranga Reddy, Medak, and Nalgonda. Hyderabad is
100% urban with a population of roughly 3,830,000
inhabitants. The neighboring area Ranga Reddy has a
similar population size (3,575,000) and is roughly half
urban and half rural. The Medak and Nalgonda areas
are similar to each other, both roughly 14% urban, com-
prised of 3,248,000 people in Nalgonda and 2,670,000 in
Medak.
The Bohol Island site was led by the Research Insti-
tute for Tropical Medicine in Manila. Bohol is a tropical
island province located in the Central Visayas of the
Philippines, with 46 municipalities and Tagbilaran City.
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Verbal autopsies were collected over the entire island, as
well as a small proportion from Manila. According to
the 2007 census, 1,230,000 people live in Bohol. Manila
is urban, while Bohol is divided into roughly 46% urban
and 54% rural.
The research site in Dar es Salaam, Tanzania, was
managed by collaborators at the Muhimbili University
of Health and Allied Sciences. Verbal autopsies were
collected from all over the city of Dar es Salaam, which
has a population of roughly 2,487,000 people according
to the 2002 census, with 94% of people living in urban
areas and 6% living in rural areas.
The Mexican study was coordinated by the National
Institute of Public Health in the Federal District and the
state of Morelos. According to the 2010 Census, 8.85
million inhabitants live in the Federal District and 1.8
million live in Morelos. Sixteen percent of the popula-
tion of the state lives in rural areas [36].
Pemba Island, Tanzania, is the smaller of the two
islands of the Zanzibar archipelago. The research there
was coordinated through the Public Health Laboratory
Ivo de Carneri as part of a collaboration between the
Ministry of Health and Social Welfare and Johns Hop-
kins University. Verbal autopsies were collected from all
areas of the island. This island has a population of
roughly 400,000 inhabitants. The island is 99% rural and
1% semi-urban.
Finally, the Uttar Pradesh site in India was led by col-
laborators at the CSM Medical University (CSMMU,
formerly, King George Medical College) in Lucknow.
Verbal autopsies were collected from a wide range of
districts in the state of Uttar Pradesh: Ambedkar Nagar,
Bahraich, Barabanki, Basti, Faizabad, Gonda, Hardoi,
Lakhimpur, Lucknow, Rae Bareli, Sitapur, Sultanpur,
and Unnao. Table 2 shows the population and urban
percentage for each of these districts.
Instrument
The instrument development was based on the WHO
standardized verbal autopsy instrument [37], which in
turn was based in part on the work of Chandramohan
et al. (1994) for adult deaths and of Anker et al. (1999)
for neonatal and child deaths [38,39]. Separate questions
were developed for neonatal deaths and stillbirths, chil-
dren 1 month to 11 years, and adults 12 years and
older. Experience gained from VA studies in Andhra
Pradesh and China where the WHO instrument, or
slight variants of it, had been applied was also consid-
ered [40,41]. A committee drawn from the principal and
associate investigators considered modifications based
on published and unpublished experiences with the
WHO instrument, including fieldwork conducted as
part of a large VA study in Thailand. The final instru-
ment was translated into the respective local languages,
and then back-translated to English by a different trans-
lator to ensure accuracy.
The PHMRC instrument is comprised of a general
information module, an adult module, and a child and
neonatal module. Skip patterns were integrated into the
general information module to collect the age of the
deceased and then direct interviewers to the correct
module to administer. In administering the WHO
Table 1 The age and sex distribution of the decedents represented in the verbal autopsy sample and the national life
expectancy for the country according to the 2010 United Nations numbers
Site National life expectancy Decedents sampled
% Male % Female % Under age 5 % Ages 5 - 59 % Ages 60+
Andhra Pradesh, India 64.2 59 41 28 55 17
Bohol, Philippines 67.8 56 44 31 38 31
Dar es Salaam, Tanzania 55.4 48 52 44 41 15
Federal District and Morelos, Mexico 76.2 53 46 21 46 34
Pemba Island, Tanzania 55.4 52 48 60 31 10
Uttar Pradesh, India 64.2 58 42 24 58 18
Table 2 The population size in thousands and percent of
population that is urban for the Uttar Pradesh, India
field sites, according to the 2001 Census of India
Population Size % Urban
Ambedkar Nagar 2,026 9
Bahraich 2,381 10
Barabanki 2,673 9
Basti 2,084 6
Faizabad 2,088 13
Gonda 2,765 7
Hardoi 3,398 12
Lakhimpur 889 7
Lucknow 3,647 64
Rae Bareli 2,872 10
Sitapur 3,619 12
Sultanpur 3,214 4
Unnao 2,700 15
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instrument, the interviewer must first determine the age
of the deceased and select the correct instrument to
deliver, which results in the potential for more inter-
viewer error and a less fluid interview. The general
information module, which is administered in all verbal
autopsies, collects items such as education of the dece-
dent, household characteristics, and a household roster.
The adult module collects a history of chronic condi-
tions, symptoms of the deceased, women’s health ques-
tions if the decedent is female, alcohol and tobacco use,
and injury information; it also transcribes any available
medical record and death certificate information. The
child and neonatal module first asks background ques-
tions on information such as whether the mother is still
alive, where the deceased was born, the size of the dece-
dent at birth, and the delivery date. The questionnaire
then ascertains whether the decedent was a stillbirth
and, if so, collects symptom questions, such as signs of
injury. If not, the questionnaire collects more general
information such as the age of the baby or child when
they became ill and the age at death. If the decedent is
under 28 days (inclusive of stillbirths), a maternal his-
tory is collected. In addition, if the decedent is under 28
days and was born live, a full set of neonatal symptom
questions are collected. If the decedent is between 28
days to 11 years, infant and child symptom questions
are asked. All available health records and death certifi-
cates are transcribed for both neonatal and child deaths.
Finally, for all ages, the open narrative section was
moved to the end of the interview, after the structured
questions. This was done to ensure that in future work,
we could remove the open-ended items without concern
that the results collected in this study were a function
of the open-ended items coming prior to structured
content.
In addition to the structural changes, there are impor-
tant differences between the PHMRC instrument and
the WHO instrument. First, the WHO adult module is
administered on ages 15 and above, while the PHMRC
adult module begins at age 12. This expansion of the
ages included in the adult module ensures that condi-
tions clinically present, such as maternal mortality in 12
to 14 year olds, are captured through this instrument.
Second, a substantial portion of the questions were
reworded to ensure clarity. Medical terminology was
converted to easily understandable descriptions to target
a lay population. For example, “Did s/he have abdominal
distension?” was reworded to “Did [NAME] have a more
than usual protruding belly?” Information was also
added for precision, or removed to ensure only the most
diagnostically relevant information was collected. Simi-
larly, we added or dropped entire questions to capture
the most essential information, while reducing the dura-
tion of the interview as much as possible. One common
question type dropped from the instrument was the
duration of certain symptoms. For example, the
PHMRC instrument asks whether adults had developed
a lump in the neck, armpit, breast, or groin but dropped
the follow up question “For how long did s/he have the
lumps?” as the presence of the symptom alone was the
most important information. Another common question
type dropped from the WHO instrument was about
treatment that had been received by the decedent, as
they were less important in informing the cause of
death. Finally, the PHMRC instrument did not include
questions about chronic conditions in children, such as
cancer, tuberculosis, and diabetes. Additional file 1 illus-
trates the content questions, such as symptoms experi-
enced by the decedent that were added or dropped
when converted from the WHO instrument to the
PHMRC instrument. The small wording changes are not
included in this additional file, though the full PHMRC
instrument is included in Additional file 2 (general mod-
ule), Additional file 3 (adults), and Additional file 4
(children and neonates) for reference.
Cause list
A key challenge for the study was to identify the cause
list for each of the three age groups for which we would
seek to collect a sample of gold standard deaths. Our
selection of the target cause list was based on considera-
tion of the WHO estimates of the leading causes of
death in the developing world in each age group, those
causes for which verbal autopsy might be able to func-
tion adequately because unique signs and symptoms
could potentially be collected in an interview, and the
potential to find, in the six sites, deaths with sufficient
laboratory, medical imaging, and pathological detail in
order that a gold standard cause of death assignment
could be made. The cause lists were also designed so
that they were mutually exclusive and collectively
exhaustive. The target cause list for adults, children, and
neonates included 53, 27, and 13 GS causes, respec-
tively, plus stillbirths (for a complete list of causes, see
Additional file 5). These cause lists are much longer
than for any previously undertaken VA validation study.
In fact, nearly all previous VA validation studies have
started with a community or convenience sample of
deaths and then ascertained cause in hospital records
rather than seeking to collect data on a list of causes by
design.
Gold standard criteria
A critical component of the study was the development,
for each cause, of clear criteria that had to be fulfilled
for a death to be assigned as a GS cause of death.
Depending on the cause of death, these criteria included
clinical endpoints, laboratory findings, medical imaging,
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and pathology. Additional file 6 (adults) and Additional
file 7 (children and neonates) provide the gold standard
criteria for each cause. These gold standard criteria were
developed by a committee of physicians involved in the
study and underwent multiple cycles of group review.
Preliminary review of hospital records in the sites
indicated it would be very difficult to identify any deaths
for some causes that would meet the strict gold stan-
dard criteria. In order to ensure that as many potentially
eligible deaths in each site as possible were collected for
the study, a less strict but nevertheless detailed level 2
set of criteria were also developed (see Additional files 6
and 7). In some cases, these level 2 criteria were further
disaggregated into level 2A and level 2B. By way of
example, the criteria for determining a death as being
due to adult breast cancer, adult acute myocardial
infarction, child pneumonia, and neonatal birth asphyxia
are shown in Table 3.
By recording the level of diagnosis for each death, we
are able to test whether the assessment of performance
for any method is affected by the level of cause of death
assignment according to our criteria.
Data collection
Identification of gold standard deaths
As described above, a stringent set of diagnostic criteria
for each cause of death was developed by a team of
study physicians before fieldwork began. Each site then
enrolled local health facilities at which medical records
would be reviewed. Consortium members led a two-day
training at each of the sites to train the reviewers in the
gold standard definitions, the protocols for identifying
cases meeting these criteria, and the procedure for
extracting the pertinent medical information. Each
reviewer was provided a pocket guide detailing the
necessary criteria for each gold standard cause of death.
The medical information from qualifying records was
extracted using a standard medical data extraction form
(MDEF, see Additional file 8), which the study team
developed. Once eligible records were extracted, a local
physician reviewed the medical information and deter-
mined the gold standard level of the particular case
according to the diagnostic criteria outlined for each
level for each cause. The following information details
the specific protocol followed by each research site.
In Andhra Pradesh, four hospitals were recruited for
the study. Three are government hospitals - Gandhi
Hospital, Osmania General Hospital, and Chest Hospital
- and one is a private hospital, CARE Foundation. There
was 24-hour surveillance at the hospitals and all patients
were enrolled with their addresses. Study supervisors
collected information on all deceased patients from all
wards, and clinicians involved in the study then
reviewed the case sheets to select those that conformed
to the gold standard criteria (levels 1, 2A, and 2B). The
medical information from all qualifying cases selected by
the clinicians was extracted and sent to the George
Institute Hyderabad office for enrollment in the verbal
autopsy study.
In Bohol, the majority of deaths were reviewed at the
Bohol Regional Hospital. This facility is the referral hos-
pital for Bohol Province with the highest available stan-
dards of clinical investigation and hence diagnosis.
Three nurses monitored all deaths in the hospital. They
ensured that all reports of investigations (imaging and
laboratory) were located and attached to the charts. In
addition, to augment the number of deaths collected,
467 deaths were recruited from two hospitals in Manila:
the Veterans Memorial Medical Center and the Rizal
Medical Center. In all locations, the nurses summarized
the case notes, including reports of investigations, onto
the medical data extraction forms. MDEFs were first
reviewed by two study physicians who assigned cause of
death and decided by diagnosis and GS level which VAs
should not be collected. Deaths were reviewed as soon
as possible after the death.
At the Dar es Salaam site, five health facilities were
used as recruitment sites. These were Mwananyamala
Hospital, Temeke Hospital, Muhimbili National Hospi-
tal, Ocean Road Cancer Institute, and Hindu Mandal
Hospital. Mwananyamala and Temeke are both district
hospitals, each of which records roughly 1,500 deaths
per year. Ocean Road Cancer Institute is the only cancer
treatment facility in Tanzania and was an important
source for causes such as cervical cancer, esophageal
cancer, breast cancer, leukemia, prostate cancer, and
lymphomas. Muhimbili National Hospital is a referral
and teaching hospital with a higher mortality rate than
the other enrolled facilities. Hindu Mandal Hospital is a
private hospital in the heart of Dar es Salaam. It has a
well-established HIV/AIDS clinic and commonly
receives noncommunicable disease cases. At each loca-
tion, a nurse affiliated with the study reviewed medical
records to identify qualifying cases. The cases identified
by the nurses were reviewed by physicians, who filled
out the MDEFs with the gold standard levels for the
cases that were eligible for enrollment. The nurses
spoke with family members of the deceased if present at
the hospital to enroll them in the study, collect their
consent, and obtain mapping information and directions
for a verbal autopsy interview.
In Mexico, after obtaining authorization to work in
each medical unit, a group of six trained physicians
reviewed the medical records of cases (and when avail-
able the reports from autopsies) that could be included
in the study, filled an extraction form for each case, and
classified them as levels 1, 2, or 3 according to the gold
standard criteria proposed by the PHMRC. Only cases
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classified as levels 1 and 2 were considered eligible for
the study. The original design considered the inclusion
of only one to three large hospitals in Mexico City, but
due to the difficulty of completing the quota of gold
standard cases, hospitals from the health service net-
work of the Federal District government and from the
Ministry of Health of the state of Morelos were
included. The data were collected from 36 public hospi-
tals: 33 from the Federal District and three from
Morelos.
In Pemba, there are four major government hospitals
on the island, though most facilities do not have a certi-
fied medical doctor present and are managed by medical
assistants and nurses. Surveillance systems were put in
place in all four hospitals to identify deaths and to clas-
sify them into GS categories. The hospital supervisor
recorded complete identification information upon
admission of each patient, and the attending physician
medical assistant confirmed the admission diagnosis.
Hospital supervisors ensured that the signs and
Table 3 Examples of gold standard criteria for adult breast cancer, adult acute myocardial infarction, child
pneumonia, and neonatal birth asphyxia
Adult breast cancer
Level 1 One of the following:
• Operative specimen with histological confirmation
• Biopsy/fine needle aspiration cytology
Level
2A
Both of the following:
• Mammography diagnosis
• Imaging evidence of metastases in bone, lung, etc. based on CT scan/MRI/X-rays
Level
2B
Patient under treatment from a recognized cancer hospital or cancer unit for breast cancer in cases where the basis for the initial
diagnosis is no longer available.
Adult acute myocardial infarction
Level 1 Evidence of acute MI within three months preceding death based upon one or more of the following:
• Cardiac perfusion scan
• ECG changes
• Documented history of CABG or PTCA or stenting
• Coronary angiography
• Enzyme changes (any troponin elevation or CK-MB isoenzyme elevation >2 times the upper limit of normal) in the context of
myocardial ischemia
Level
2A
Clinical evidence of the following:
• Sudden death within six hours of the onset of characteristic shock and chest pain when the case has been witnessed by a physician
Child pneumonia
Level 1 Chest X-ray showing primary end-point consolidation, pleural effusion or other consolidation/infiltration, plus two or more of the
following:
• Respiratory rate >70/minute
• Severe lower chest indrawing
• Abnormal breath sounds (i.e., grunting, decreased breath sounds, crepitations)
• Rectal temperature >38°C or <36°C
• Oral or axillary temperature >37.5°C or <35.5°C
Neonatal birth asphyxia
Level 1 Each of the following:
• Failure both to breathe spontaneously and to cry at birth
• No major congenital abnormality
• Not a stillbirth (one or more signs of life at birth like pulse or movement)
Plus one of the following in the 24 hours after birth:
• Not feeding
• Hypotonia
• Seizures
• Needed and failed resuscitation at birth
Level 1 is the most stringent criteria, while level 2A or 2B were also collected for some causes.
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symptoms experienced by the patient were recorded and
that a mortality form with the cause(s) of death was
filled out by the attending physician in the event of a
death. All forms were sent back to the field headquar-
ters for data entry. A computer algorithm was run to
identify cases meeting GS criteria, and all GS cases were
recorded in a database. A computer listing was prepared
with identifier information to schedule the VA
interviews.
In Uttar Pradesh, the gold standard deaths were
enrolled at CSMMU, Lucknow, which is a tertiary care
government facility with patient inflow from all over
Uttar Pradesh and bordering states, including districts in
the neighboring country of Nepal. The catchment area
spreads over a radius of more than 500 km, of which
about 85% cases come from 13 districts surrounding
Lucknow. There was 24-hour surveillance at facilities
and all patients were enrolled with an address. When a
death occurred, the project medical officer reviewed the
patient case sheet in consultation with the resident doc-
tor in order to assess the GS levels against standard
criteria.
VA interview
Once enrolled, the VA interviewers at each site attended
a training session led by consortium members using
standardized materials and an interviewer’s manual. The
training manuals provided information on the study
background, the roles and responsibilities of the VA
interviewer, background on how VA cases were selected,
instructions for administering the questionnaire, and
information on every question in the instrument. The
manual provided guidance on how to handle an array of
questions or concerns, tips for building rapport with the
respondents, and probing as needed to collect reliable
information.
Following the training, VA assignments were given to
interviewers blinded to the medical information or
cause of death of the decedent along with directions or
map queues to the households. In some sites the
families were contacted in advance to schedule an
appointment, though this decision was left to the sites’
discretion. All interviews were collected after a culturally
appropriate grieving period had passed. The minimum
grievance period was six days in Bohol and the maxi-
mum was six months in Mexico (as required by the
ethics boards at the hospitals). The maximum amount
of time post-death that an interview was collected was
eight months in the Mexico site.
The rate of interview refusals varied by site from 1.8%
to 9.5%. For those that consented to a verbal autopsy,
the instrument was administered on paper in the field,
and returned to the field headquarters for double data
entry. Interviews lasted an average of 45 minutes across
all of the sites.
Quality control of fieldwork and data entry
To ensure the highest quality data was collected, quality
control checks were performed both at the individual
site level, as well as at the Institute for Health Metrics
and Evaluation (IHME), where all data were transmitted
through a secured password-protected site for analysis.
In all sites, supervisors were trained in the protocols
for monitoring quality control at the site level. Supervi-
sors were instructed to observe VA interviewers in the
field during the early stage of data collection to ensure
they were conducted properly and to provide guidance.
Supervisors additionally checked every VA form col-
lected throughout the study to ensure that it was filled
out consistently and correctly. If issues were identified
by the supervisor, a reinterview was conducted as
needed. The field interviewers had periodic meetings
with their supervisors to discuss performance, progress,
and challenges. Supervisors at most sites additionally
reinterviewed a portion of the verbal autopsies to spot
check the quality of the information collected.
At IHME, we systematically evaluated all datasets elec-
tronically for numerous types of quality issues by a com-
prehensive set of codes. First, we reviewed the dataset
for missing values and for incorrect skip patterns that
result in specific questions having been filled in or left
blank erroneously. The dataset was also evaluated to
determine if any of the observed values fell outside of
expected ranges. For example, if the response for a neo-
natal symptom duration was greater than 28 days (the
cutoff for classification as a neonatal death), this value
was flagged. Next, if the dataset was submitted in multi-
ple sections, we examined the final comprehensive data-
base for any technical issues that may have occurred in
merging the individual files. Finally, we merged the data-
set with the gold standard medical record information,
which was separately transmitted to IHME by the site
coordinator. We examined the observations for consis-
tency between the two sources of information, such as
the sex of the decedent as reported in the medical
record and as reported by the verbal autopsy respon-
dent. Any issues determined through this stringent
checking process were compiled into a report and sent
to the site to review. Site coordinators were asked to
speak with the interview staff and rectify any correctable
issues such as data entry mistakes.
Generation of dichotomized variables
In addition to the full dataset as it was collected, we
have also created a series of dichotomous variables from
each of the polytomous (categorical) and continuous
(duration) variables. Some analytical methods can only
use dichotomized variables, so this effort to create the
dichotomous variables increases the information avail-
able to these types of empirical methods. For each
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continuous duration item, depending on the item, we
identified a short or long cutoff. For example, a duration
of 8.8 days marks long duration of a fever. If a VA
reports a fever of 10 days, it is considered to have the
symptom of “having a long fever.” We determine the
cutoff as being two median absolute deviations above
the median of the mean durations across causes (MAD
estimator). The MAD estimator can be used as a robust
measure of the standard deviation and is especially use-
ful in cases where extremely long durations may be
reported, which would bias measures such as the stan-
dard deviation. Additional file 9 shows the cutoffs for
each item developed in this way. For polytomous vari-
ables, we examined the pattern of the endorsement rates
across causes and mapped the categories into two, thus
creating a dichotomous version of the variable. For
example, we judged that there was a stronger signal pro-
duced by combining moderate and severe fevers. Addi-
tional file 10 shows the mapping of each response
category into dichotomous variables. Based on the data
collected, some polytomous variables appeared to have
little or no information content and were not mapped
into a dichotomous form. These low information con-
tent items are shown in Additional file 11. This exercise
was undertaken for neonatal, child, and adult modules
separately.
Inclusion of health care experience
There has long been concern that the performance of a
VA instrument and the associated analytical method for
assigning cause could be different for deaths where the
decedent died in a hospital or had made extensive use
of health services prior to death, compared to deaths
with no health care experience (HCE). As an attempt to
examine how VA may work in communities with lim-
ited or no access to health care services, Murray et al.
[12] studied how PCVA and the Symptom Pattern
Method performed when all items referring to use of
health services such as “Have you ever been diagnosed
with...” or hospital records or death certificates were
excluded from the analysis. They showed that, in China,
recall of the household or possession of medical records
recorded in the VA interview had a profound effect on
both the concordance for PCVA as well as the perfor-
mance of the Symptom Pattern Method.
Given this empirical finding, we believe it is useful to
test how excluding household recall of health care
experience likely provides a more realistic assessment of
how VA performs in communities without access to
health services. As such, we have created two versions
of the datasets developed above, one version with all
variables and one version excluding recall of health care
and medical records. Specifically, the without HCE data-
set excludes the following information. First, a series of
questions asked if the deceased had any specified condi-
tions, which would likely indicate a health care provider
had diagnosed the individual. Each of the following con-
ditions was asked: “Did decedent have [asthma, hyper-
tension, obesity, stroke, tuberculosis, AIDS, arthritis,
cancer, COPD, dementia, depression, diabetes, epilepsy,
heart disease]?” Second, if any medical records were
available, the interviewer was asked to provide a tran-
scription of the last note on the medical record. Third,
if a death certificate was available, the interviewer was
asked to record the immediate cause of death, first
underlying cause, second underlying cause, third under-
lying cause, and contributing causes from the death cer-
tificate. Finally, at the end of the questionnaire, an
open-ended section was provided to collect any com-
ments from the interviewer, as well as to ask the
respondent “to summarize, or tell us in your own
words, any additional information about the illness and/
or death of your loved one?” Excluding this entire sec-
tion excludes both open narrative recall of HCE but
also, in the case of PCVA, excludes any other informa-
tion on timing and sequencing of signs and symptoms
that might be conveyed in this section.
Processing free text for use in empirical methods
The structured instrument includes various open text
items. First, some questions in the instrument ask the
respondent to choose from a list of specified response
options. For example, “Where was the rash located?”
has the following response options: face, trunk, extremi-
ties, everywhere, or “other (specify: ____).” If the
response is not one of the listed options, the respondent
is asked to fill in the location of the rash as the “other”
response. The questions that include an “other” free text
response option are as follows: “Where was the rash
located?"; “Where was the pain located?"; “Which were
the limbs or body parts paralyzed?"; “What kind of
tobacco did [NAME] use?"; “Did [NAME] suffer from
an injury or accident such as a ____?"; “Where was the
deceased born?"; “What were the abnormalities?” in
reference to any abnormalities at time of delivery;
“Where did the deceased die?"; “What was the color of
the liquor when the water broke?” in reference to labor;
“Where did the delivery occur?"; and “Who delivered
the baby?” In the questions that collect information
about a health facility or midwife, free text responses
collected the name and address of the place or person.
In addition to these free text items, if any medical
record or death certificates were available, the inter-
viewer was asked to transcribe the information from the
records as free text. Finally, at the end of each interview,
the open narrative question “Summarize, or tell us in
your own words, any additional information about the
illness and/or death of your loved one?"(as described
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above) was collected in addition to any notes from the
interviewer.
Open text could in theory be highly informative, espe-
cially household recall of HCE and an interviewer’s
direct recording of death records or hospital records
kept by the household. These observations are likely to
be available in populations with some access to health
care services. To make this information available to
automated methods, we processed open text in the fol-
lowing steps. First, all free text was compiled into a
database and a dictionary was created to map all similar
words to the same stem word. For example, the terms
AMI, myocardial infarction syndrome, acute myocardial
infarction, ISHD, MI, coronary heart disease, CHD,
IHD, MCI, and MYIN would all be mapped by the dic-
tionary into the same variable ("IHD: Acute Myocardial
Infarction”). Next, a program called README [42]
extracts each individual variable and assigns a frequency
count for the number of times it appears in the entire
free text database. Variables that are not deemed to be
diagnostically relevant or that are very low in frequency
are then dropped from the dataset. The final product is
a condensed dictionary of medically important terms
consisting of 106 variables for adults, 90 for children,
and 39 for neonates. These terms are added as addi-
tional binary symptoms (present or not present) in the
VA database. If any of the terms appear in the free text
for a particular death, it is counted as a positive endor-
sement for that symptom. These symptoms are not used
in the “without” HCE dataset. Additional file 12 provides
the comprehensive dictionary that was developed.
Analysis datasets
For empirical VA methods that must be developed using
the pattern of responses observed in a dataset, validation
needs to be undertaken on a set of deaths that were not
included in the development of the method. This is the
concept of a training dataset distinct from a test dataset.
Further, as recommended in Murray et al. [15] it is
important to have test datasets with widely varying
cause-specific mortality fractions (CSMFs) so that a VA
method does not by chance appear to be better than
another because of the specific CSMF composition in
the training set. To facilitate strict comparability, we
have created 500 train-test dataset pairs. Each pair was
created by first splitting the data randomly (without
replacement) into 75%/25% training and test datasets,
cause by cause, and then resampling the data in the test
dataset (with replacement) to have 7,836 adult, 2,075
child, 1,629 neonatal, and 1,002 stillbirth deaths, match-
ing a cause composition drawn from an uninformative
Dirichlet distribution (Figure 1). In other words, each
test dataset has been resampled to have a different
CSMF composition. Because the CSMF compositions
have been drawn from an uninformative Dirichlet,
across the 500 test datasets, there are cases where any
given cause has a cause fraction near zero and cause
fractions as high as 20% or more. By the nature of this
sampling strategy, there is no correlation between the
CSMF composition of the training and test dataset pairs.
Shortened cause lists
In order to have an efficient cause list for the analysis,
we have reduced it in two steps as illustrated in Table 4.
From the original gold standard target cause list we
received deaths from the sites for 53 diseases in adults,
27 in children, and 13 in neonates, excluding stillbirths.
The first step was to select only those causes with 15 or
more deaths (see Additional file 5 for a detailed map-
ping), and due to that decision we reduced the list into
46 adult causes, 22 child causes, and 12 neonate causes,
excluding stillbirths. For instance, pelvic inflammatory
OriginalDatawith
ValidatedGoldStandard
TrainDataset
TestDataPool
Random
CSMFvia
Dirichlet
TestDataset
Sampling
without
replacement
75%
25%
Samplingwith
replacement
Figure 1 The process of generating 500 test and training
datasets (done separately for each cause of death).
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diseases, uterine cancer, and dementia in adults; AIDS
with tuberculosis in children; and meningitis in neonates
had fewer than 15 deaths each. We also eliminated per-
tussis in children and neonatal tetanus because no per-
tussis and only four neonatal tetanus deaths were
gathered. These deaths were assigned to one of the
remaining categories, such as residual categories like
“other defined cancers” or “other childhood infectious
diseases.” In the next step we explored the frequency
with which one cause was erroneously classified as
another cause in the analysis. For example, deaths due
to maternal hemorrhage were often assigned to anemia
in the analysis and vice versa. Similarly, all types of dia-
betes in adults (diabetes with coma, with renal failure,
or with skin infection), sepsis with and without local
bacterial infection in children, and respiratory distress
syndrome in neonates regardless of the gestational age
were all frequently hard to differentiate in the analysis.
The causes that were frequently confused with each
other were aggregated into a new cause in the final ana-
lysis cause list. For example, all six maternal causes
were combined into one maternal category. After this
step, the final cause list for analysis had 34 causes for
adults, 21 for children, and 10 for neonates, excluding
stillbirths.
Results
Table 5 shows that of the 12,542 deaths collected as
gold standard cases for the study, the vast majority
(88%) were deaths that met the highest level of GS cri-
teria (level 1). This number varies from 84% in Bohol to
91% in Dar es Salaam; and by age, 86% of adult deaths
were level 1, 81% of child deaths, and 99.7% of neonate
deaths. The majority of the remaining 12% level 2
deaths were adults.
It is interesting to note the cause distribution by qual-
ity of the gold standards. Table 6 presents the break-
down of how many level 1 and level 2 GS cases were
collected for each of the 53 adult causes. Eighty-six per-
cent of adult deaths were level 1, 13% were level 2A,
and 1% were level 2B. Twenty five causes of death,
which represent 47% of all adult causes, were exclusively
level 1. For the remaining 28 causes, the frequency of
level 1 deaths varies, such as cirrhosis and asthma with
less than 30% level 1 cases; pneumonia and sepsis with
between 30% and 60% level 1 cases; and stroke, lung
and esophageal cancers, and tuberculosis with between
60% and 75% level 1 cases. Table 7 shows the results for
the 2,075 deaths in children. Eighteen causes of death,
which comprise 67% of all of the child causes, reached
the level 1 gold standard. Another six causes do not
achieve more than 60% of gold standard level 1 and
vary from 0% (measles) to more than 50% (malaria,
pneumonia, and sepsis). Table 8 shows that the level of
quality was very high for the 1,629 neonatal deaths and
1,002 stillbirths.
The distribution of cases (all criteria levels combined)
across the six sites is shown in Additional file 13. The
relative distribution of cases by age of death across sites
reflects their overall progress with mortality transition.
Thus adult deaths were comparatively fewer in Pemba
compared to all other sites where 1,200 to 1,600 cases
were typically collected. Larger numbers of child deaths
were collected in Dar es Salaam and Uttar Pradesh,
where child death rates are higher than elsewhere. Simi-
lar numbers of neonatal deaths were collected in each
site (250 to 400) except for Dar es Salaam. In this case,
the site collected VAs on a significantly higher number
of neonatal deaths (1049) than was targeted, as the site
had the VA interviewer capacity to easily add these
cases as they were identified. For example, while the tar-
geted number of stillbirth deaths was 100, the Dar es
Salaam site was able to easily collect interviews on 432
cases to help build a more robust dataset.
Discussion
PHMRC was able to obtain completed VA interviews for
more than 12,000 deaths with GS assignment of true
cause of death. Because of the poor quality of medical
record-keeping and limitations of diagnostic technology
in many hospitals, to identify more than 12,000 GS
deaths required reviewing and screening a much larger
number of records. While it was difficult in many sites
Table 4 Reduction in number of causes to the final
analysis cause list, excluding stillbirths
Adult Child Neonate
Target cause list 53 27 13
>15 deaths 46 22 12
Cross classification 34 21 10
Table 5 Numbers of VAs collected by site and gold
standard level
Site Adult Child Neonate Total
Level
1
Level
2
Level
1
Level
2
Level
1
Level
2
Andhra
Pradesh
1,285 269 385 66 376 1 2,382
Bohol 998 262 234 30 374 0 1,898
Dar es
Salaam
1,556 162 366 106 1,047 2 3,239
Mexico 1,373 215 124 4 313 2 2,031
Pemba
Island
266 31 156 105 261 3 822
Uttar
Pradesh
1,277 142 412 87 251 1 2,170
Total 6,755 1,081 1,677 398 2,622 9 12,542
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to obtain sufficient documentation for some causes of
death overall across all six sites, we were able to find
enough deaths for 46 adult causes, 22 child causes, and
12 neonate causes, excluding stillbirths, from the origi-
nal cause list. The implementation of the project
revealed just how poor the quality of medical records
and diagnosis is in some institutions. This finding reaf-
firms our original hypothesis that convergent validity
between verbal autopsy and poorly assigned hospital
cause of death is not a measure of criterion validity.
An important potential limitation of the study is the
extent to which the cause of death based on fulfilling
the clinical, laboratory, medical imaging, and tissue
pathology criteria in this study are the true cause of
death. Studies in high-resource settings [43] suggest that
clinical diagnosis compared to postmortem autopsy may
differ in up to 25% of cases. These studies, however,
exaggerate the limitations of our study using clinical
diagnostic criteria for three reasons. First, autopsies are
much more likely to be undertaken in medico-legal
cases or cases with uncertain clinical diagnosis. Shojania
et al. found that once the inherent selection bias of
postmortem autopsy is taken into account, clinical diag-
nosis and postmortem autopsy agree more than 90% of
the time [44]. Second, these comparisons are for all clin-
ical diagnoses, not for the subset that meets our clearly
defined and stringent criteria. In general, less than one-
third of hospital deaths in our study fulfilled our diag-
nostic criteria even in the most sophisticated hospitals.
It is a reasonable assumption that the concordance
between the clinical diagnosis and postmortem autopsy
would be even higher in the subset meeting our criteria.
Finally, the definition in these studies of major diagnos-
tic discrepancy is for clinical purposes, not for the pur-
poses of assigning underlying cause of death. For the
latter effort, some of the major discrepancies would not
move deaths between cause of death categories used in
this study.
Some readers may object to the use of “gold standard”
in describing our dataset. We believe, however, that we
have implemented the best possible approach to
Table 6 Numbers of VAs collected by cause of death and
gold standard level for adult causes
Adult causes Level 1 Level 2A Level 2B
AIDS 345 0 8
AIDS with TB 148 0 0
Acute myocardial infarction 376 24 0
Anemia 68 0 0
Asthma 13 34 0
Bite of venomous animal 66 0 0
Breast cancer 179 3 12
COPD 170 1 0
Cervical cancer 127 23 5
Cirrhosis 82 231 0
Colorectal cancer 85 6 8
Dementia 1 0 0
Diabetes with coma 144 0 0
Diabetes with renal failure 156 0 0
Diabetes with skin infection/sepsis 114 0 0
Diarrhea/dysentery 221 7 0
Drowning 106 0 0
Epilepsy 47 1 0
Esophageal cancer 26 13 1
Falls 173 0 0
Fires 122 0 0
Hemorrhage 111 3 0
Homicide 167 0 0
Hypertensive disorder 107 6 0
Congestive heart failure 221 0 0
Inflammatory heart disease 42 0 0
Leukemia 71 2 5
Liver cancer 29 0 2
Lung cancer 66 36 4
Lymphomas 74 0 3
Malaria 89 11 0
Mouth/oropharynx cancer 22 0 0
Obstructed labor 17 1 0
Other cancers 142 0 0
Other cardiovascular diseases 153 0 0
Other digestive diseases 166 0 0
Other infectious diseases 258 0 0
Other injuries 103 0 0
Other noncommunicable diseases 200 0 0
Other pregnancy-related deaths 89 0 0
Ovarian cancer 32 1 0
Pelvic inflammatory disease 5 0 0
Pneumonia 310 229 0
Poisonings 86 0 0
Prostate cancer 40 8 0
Table 6 Numbers of VAs collected by cause of death and
gold standard level for adult causes (Continued)
Renal failure 411 2 0
Road traffic 202 0 0
Sepsis 24 46 0
Stomach cancer 50 10 2
Stroke 378 252 0
Suicide 124 0 0
TB 196 79 0
Uterine cancer 1 1 1
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assigning causes of death. In nearly all settings, post-
mortem rates are low and subject to severe selection
bias toward diagnostically challenging and nonrepresen-
tative deaths for a cause. For both implementation and
selection bias reasons, we do not foresee VA validation
studies being undertaken using large samples of deaths
with postmortem autopsies. Clearly defined clinical,
laboratory, imaging, and tissue pathology criteria as used
in this study are the best that can be implemented. As
such, we believe the use of the term gold standard for
this dataset is appropriate.
A particularly vexing issue in VA validation studies is
that by their nature they are conducted on deaths that
have occurred in hospital. What would be the perfor-
mance of VA for deaths in the community? There are
potentially three distinct aspects to this question. First,
the cause-composition of deaths in the hospital and the
community will be different. Fortunately, because we
create multiple test datasets with widely varying cause
compositions, this issue will not influence the results
from VA validation studies as long as the methods
recommended by Murray et al. [15] are followed. Sec-
ond, contact and experience with the health system
could change the way in which household members
recall certain symptoms or signs. If it does, then VA
may capture more information in those cases with hos-
pital experience than when implemented in a population
with little or no experience of health care. Given that all
validation studies require some diagnostic information
on the course of illness prior to death, no validation
study can ever investigate this question. This is an
unfortunate reality; we believe that constructing a data-
set, as we have done, that excludes all information from
the household about medical experience prior to death
Table 8 Numbers of VAs collected by cause of death and gold standard level for neonatal causes
Neonate causes Level 1 Level 2A Level 2B
Birth asphyxia 461 0 0
Congenital malformation 250 0 0
Meningitis (serious infection) 6 0 0
Pneumonia (serious infection) 84 5 0
Preterm delivery (<33 weeks gestational age [GA]) without respiratory distress syndrome (RDS) 353 0 0
Preterm delivery (with or without RDS) and sepsis 75 1 0
Preterm delivery (without RDS) and birth asphyxia 89 0 0
Preterm delivery (without RDS) and sepsis and birth asphyxia 34 0 0
Respiratory distress syndrome (33-36 weeks GA) 13 0 0
Respiratory distress syndrome (<33 weeks GA) 97 0 0
Sepsis (serious infection) 127 1 0
Sepsis with local bacterial infection 32 1 0
Stillbirth 1,001 1 0
Tetanus 4 0 0
Table 7 Numbers of VAs collected by cause of death and
gold standard level for child causes
Child causes Level 1 Level 2A Level 2B
AIDS 19 0 0
AIDS with TB 1 0 0
Bite of venomous animal 54 0 0
Diarrhea/dysentery 255 1 0
Drowning 82 1 0
Encephalitis 41 0 0
Falls 49 0 0
Fires 68 0 0
Hemorrhagic fever 51 0 0
Malaria 59 58 0
Measles 0 23 0
Meningitis 58 0 0
Other cancers 28 0 0
Other cardiovascular diseases 76 0 0
Other defined causes of child deaths 182 0 0
Other digestive diseases 48 0 0
Other infectious diseases 60 0 0
Other respiratory diseases 12 0 0
Pertussis 0 0 0
Pneumonia 272 224 1
Pneumonia and diarrhea 35 3 0
Poisonings 18 0 0
Road traffic 92 0 0
Sepsis (with local bacterial infection) 22 15 0
Sepsis (without local bacterial infection) 39 67 0
TB 4 5 0
Violent death 52 0 0
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is the closest we can come in a validation study to
understanding how VA will perform in a poor, under-
served community. While it is theoretically possible that
household recall of symptoms and signs will be different
if someone has experienced health care prior to death,
there is in fact no direct evidence for this hypothesis,
nor is it clear how it would be tested. Third, the clinical
course and thus the signs and symptoms related to a
cause of death may be influenced through contact with
the health system. As with the second limitation, there
is unfortunately no way to investigate this important
issue. We simply have no way to figure out the true
cause of death for deaths that have occurred in the
community with no contact with health services.
Ideally, all countries would have in place functioning
vital registration systems that capture all deaths and
include a medically certified cause of death according
to the procedures and rules of the International Classi-
fication of Diseases in force at the time. While pro-
gress toward this goal is being made, it is painfully
slow, and without greater government commitment,
will not be a reality for most developing countries for
decades to come [45,46]. To meet urgent policy and
planning needs, countries will have no alternative but
to introduce verbal autopsy, at least for deaths that
occur outside hospitals. It is critically important that
they have confidence in the VA methods they use, and
that they understand the validation and performance
characteristics of those methods. We believe that to do
so, validity and comparative performance must be
assessed against rigorous, standardized criteria that
unambiguously identify the cause of death, and that
are not influenced whatsoever by the quality, usually
very poor, of medical records or the diagnostic biases
of physicians who review them. Our study has com-
piled the first ever dataset of gold standard cause of
death assignments across six sites in four countries. It
is unlikely that a comparable dataset on VA with true
gold standard cause of death ascertainment will be col-
lected in the near future, if for no other reason than
the substantial cost and time investment. For quite
some time, therefore, the PHMRC will be the largest
and most rigorously collected VA validation set. We
intend to make the dataset publicly available in the
hope that it will serve as a resource for the broader
VA scientific community interested in developing and
testing new methods. For this reason, we plan to
release to the public an anonymized version of the
dataset once the primary set of analyses from the
investigators have been published.
One lesson learned from the complexity of converting
free text into dichotomous variables is that future VA
instruments may want to incorporate a series of check-
list questions based on the free text variables that
improve VA performance. Rather than free text, items
could be included such as “Did anyone tell you or do
you have any documentation mentioning acute myocar-
dial infarction, MI, ischemic heart disease, or coronary
heart disease?” These checklist items would be com-
pleted by the interviewer after questioning the respon-
dent and examining the medical records and other
documentation available. In this way, the task of reading
free text and translating it through a dictionary would
be simplified and focused only where it is likely to
change the results.
Conclusion
We have described the development and usefulness of
the largest, perhaps only dataset with gold standard
cause of death assignment and matching verbal autop-
sies for more than 12,000 deaths in four countries.
We expect that this will facilitate further development
of verbal autopsy and perhaps other cause of death
measurement approaches in countries with poor vital
registration and certification practices. The utility of
this dataset will undoubtedly improve if additional
cases, in different populations, and for different dis-
eases than those reported here, are added in future
studies, provided the same protocols and standards
are applied. In this way, confidence in the utility of
verbal autopsy methods will increase and result in
their wider application in countries to reduce ignor-
ance about the comparative importance of leading
causes of death.
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